Project Details
Description
The objective of this Phase I study is to determine the maximum tolerated doses (MTD) of docetaxel and carboplatin in combination, when given to patients with advanced solid tumors.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/95 → 9/30/97 |
Funding
- National Center for Research Resources
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.